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Abstract: 
Hospital based case control study carried out for reduced Glutathione levels (GSH), Superoxide dismutase activity (SOD), 
Total Antioxidant Potential (AOP), Malondialdehyde (MDA) and Nitrate levels in a  major referral hospital in Kashmir, 
North India involving patients with breast cancer (N=40) and healthy Controls (N=20). Patients with history of drug use or 
some other similar disorder which might influence antioxidant enzyme activity were not included in the study. The results 
were analyzed statistically using the Student’s t-test for unpaired variables. MDA, SOD and nitrite levels were increased in 
breast cancer patients as compared to controls (p<0.005, P<0.01 and P<0.05) respectively. GSH, and AOP levels in plasma of 
breast cancer patients were low as compared to healthy voluntary controls (P<0.005 and p<0.005). Increased oxidative stress 
in patients is indicated by increased SOD activity and is evident by depleted GSH levels and AOP.  
 Key words:  Reduced glutathione (GSH), thiobarbituric acid (TBA), superoxide dismutase (SOD), 
Antioxidant potential (AOP), Malondialdehyde (MDA).  
 
Introduction: 
Breast cancer is one of the most common cancers in women of developed and developing countries (1). 
Oxidative stress caused by increased free radical generation and/or decreased antioxidant level in the target cells 
and tissues has been suggested to play an important role in carcinogenesis (2-4). Free radicals are formed in 
major physiological and pathological conditions in mammalian tissues wherein structural changes in lipids, 
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proteins and nucleic acids are consistently brought (5). In healthy conditions at cellular level, a subtle balance 
exists between the free radical generation and the antioxidant defence systems. Reactive Oxygen Species (ROS) 
are essential for various normal physiological processes like cell differentiation (6), apoptosis (7), cell immunity 
(8) and cellular defense against microorganisms at low concentrations (9). Excess generation of these oxygen 
free radicals generate a phenomenon called oxidative stress which cause oxidative damage to biomolecules 
resulting in lipid peroxidation, mutagenesis and carcinogenesis. In mammalian systems the prime targets of ROS 
are the polyunsaturated fatty acids in cell membranes which later lead to its lipid peroxidation and resultant 
neoplastic transformation of the cell (10). There is accumulating evidence from animal and human systems 
implicating a role of oxidative stress and lipid peroxidation in the development of breast cancer (11). 
Experimental investigations as well as clinical and epidemiological studies confirm the involvement of singlet 
oxygen (1O2), superoxide anions (O2•¯ ), hydrogen peroxide (H2O2) and hydroxyl radical (OH•) in the etiology of 
cancer (12-13). However there are conflicting reports of tissue concentrations of malondialdehyde (MDA), 
nitrite and Vit. E in breast cancer patients and only a few studies on their blood concentrations have been 
reported so for. The present study aimed to determine the extent of oxidative stress by measuring 
malondialdehyde (MDA), nitrate, lipid hydroperoxide and total antioxidant capacity (TAC) in blood and tissue 
of patients with malignant breast tumor and benign breast disease. 
 
MATERIAL AND METHODS 
 
Subjects: 
This study was conducted in Division of Veterinary Biochemistry, SKUAST-K and in the Department 
of Biochemistry, Govt. Medical College Srinagar, Kashmir India. The patient group consisted of 40 persons with 
Breast Cancer who were treated at the department of the Medical Oncology SMHS Hospital Srinagar and 20 
healthy controls. Patients with past or present disorders which may have influenced antioxidant enzyme activity 
were not included in the study. The fasting blood samples of both groups were drawn in to citrate (3.5mg/ml 
blood) containing glass tubes and centrifuged at 480 × g for 11 minutes, and plasma samples were stored at -20 
ºC until analysis. 
 
Procedures: 
Standard procedures were adopted for the estimation of GSH, SOD, AOP and MDA levels as a measure of LP in 
the current work. 
GSH levels were estimated within one hour by method of Moron et al. (19). 25% Trichloroacetic  acid 
(TCA )was added to precipitate out and  proteins  were separated by centrifugation at  2000 g for 15 min. GSH in 
the supernatant fraction formed a  complex with 2,2’-Dinitro -5,5’- Dithio- bis- Nitrobenzoic acid (DTNB ) 
which was measured at 412 nm .  
SOD activity was determined as described by Kono  et al. (20). Photo oxidation of Hydroxylamine 
Hydrochloride was used to generate the superoxide anion. This anion reduces nitroblue tetrazolium (NBT) to 
formazan, which is monitored at 560 nm. SOD of the sample removes the superoxide anion and inhibits the 
reduction. The level of this reduction was used as a measure of SOD activity. 
Total amount of lipid peroxidation products in the plasma of 40 patients & 20 healthy volunteers was 
estimated using the thiobarbituric acid (TBA) method (21), which measures the TBA reactive products chiefly 
malondialdehyde (MDA). In brief, 1.0 ml of plasma, 1.0 ml of normal saline and 1.0 ml of 25% TCA were 
mixed and centrifuged at 2000 for 20 min. One ml of protein free supernatant was taken, mixed with 0.25 ml of 
1% TBA and boiled for 45 min at 95o C. After cooling, the intensity of the pink color of the product obtained 
was read at 532 nm. 
Nitrite as a constituent in the estimation of lipid peroxidation was measured using Griess reagents (22). 
The 100 µL of serum were added to 50 µL 1% sulfanilamide (Griess reagent 1), followed by the addition of 50 
µL 0.1% N-(1-napthyl) ethylenediamine (Griess reagent 2), and later absorbance was measured at 550 nm after 
15 min. 
Statistical analysis: 
The results were analyzed statistically using the Student’s t-test for unpaired variables to evaluate the 
significance of differences between the mean values of the two studied groups. 
Results:  
The results of different biochemical parameters estimated in the study are presented in Table-1. 
 
DISCUSSION:  
Damage to the breast epithelium by reactive oxygen species can lead to fibroblast proliferation, 
epithelial hyperplasia and breast cancer. Studies have shown increased lipid peroxidation in solid tumours (23, 
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24). Increased generation of oxygen free radicals, such as O2 and H2O2, can induce the activity of superoxide 
dismutase. An increase in total and mitochondrial SOD activities due to over expression were observed from 
patients with breast carcinoma has been reported (25, 26). Glutathione, an important substrate for glutathione 
Peroxidise and Glutathione–S-Transferase has been documented to have regulatory effects on cell proliferation 
(27). GSH is recognized as a potent antioxidant and enzyme cofactor and is under tight homeostatic control for 
its synthesis, recycling and utilization .Free radical and other oxidative agents in the biological systems are 
known to deplete GSH and this study revealed that in glutathione cycle depletion has outpaced synthesis of 
glutathione.  
Lipid peroxidation and Oxidative stress caused by increased free radical generation and decreased 
antioxidant level in the target cells and tissues is suggested to play an important role in carcinogenesis (28-31). 
Potentially cytotoxic agents that are important in the etiopathogenesis of several diseases are generated by the 
interaction of ROS and RNS. Earlier studies showed the involvement of ROS induced lipid peroxidation in 
cancer initiation, progression and promotion (32,33). In recent years, using MDA as a marker of oxidative stress, 
there has been a growing interest in studying the role played by lipid peroxidation in cancer progression. MDA is 
low-molecular weight aldehyde that can be produced from free radical attack on polyunsaturated fatty acids. 
Some studies reported that increased plasma MDA levels in breast cancer compared with the levels in benign 
breast disease (34). In our study, serum MDA levels were elevated in the breast cancer patients as compared to 
controls which confirm the role of lipid peroxidation in the promotion of breast cancer.  
Presence of NO is well-known in human biological fluids, suggesting its role in physiological and 
pathological processes. The NO readily oxidized to nitrite and nitrate in biological systems. It exhibits a dual 
role, with regard to the complex mechanism of tumour invasion and metastasis and could either mediate 
tumorocidal activity or promote tumour growth (35). In this study, we demonstrated that in breast cancer patients, 
the serum and tissue levels of nitric oxide are significantly increased compared to benign breast disease which 
depicts its role in the carcinogenesis of breast tissue. 
 
 
Conclusion :  
The study reveals that there is increased oxidative stress related damage leading to increased LP is Breast cancer 
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Patients Controls P 
GSH (µM/l) 2.58 ± 0.22 4.76 ± 0.52 P<0.005 
 
SOD (U/ml) 5.24 ± 0.69   4.14 ± 0.56U P<0.01 
 
AOP(nmol-1/ml.h) 0.020± .011 0.042 ± 0.018 P<0.005 
 
MDA (nmol/ml) 0.88 ± 0.20 0. 53 ± 0.16 P<0.005 
 
Nitrite (µmol/L) 14.70±3.93 5.58±1.08 P<0.05 
 
 
